2021
DOI: 10.3389/fphys.2021.682446
|View full text |Cite
|
Sign up to set email alerts
|

Automated Localization of Focal Ventricular Tachycardia From Simulated Implanted Device Electrograms: A Combined Physics–AI Approach

Abstract: Background: Focal ventricular tachycardia (VT) is a life-threating arrhythmia, responsible for high morbidity rates and sudden cardiac death (SCD). Radiofrequency ablation is the only curative therapy against incessant VT; however, its success is dependent on accurate localization of its source, which is highly invasive and time-consuming.Objective: The goal of our study is, as a proof of concept, to demonstrate the possibility of utilizing electrogram (EGM) recordings from cardiac implantable electronic devic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 50 publications
0
15
0
Order By: Relevance
“…the origin of the so-called ventricular ectopic beat. Several studies already proved the applicability of machine learning approaches to the problem of localizing the activation wave source with simulated signals, partly by first estimating the activation times on the heart surface, partly by using pacing signals [37,5]. Learning from patient-specific simulated signals is another already used approach which helps to estimate activation times and the location of the activation source on clinical data [17,2].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…the origin of the so-called ventricular ectopic beat. Several studies already proved the applicability of machine learning approaches to the problem of localizing the activation wave source with simulated signals, partly by first estimating the activation times on the heart surface, partly by using pacing signals [37,5]. Learning from patient-specific simulated signals is another already used approach which helps to estimate activation times and the location of the activation source on clinical data [17,2].…”
Section: Introductionmentioning
confidence: 99%
“…Besides, simulated data can help to overcome the shortage of clinical data in this field, which often prevents the use of machine learning approaches. Instead of directly estimating a set of coordinates as the origin of the activation, it is also possible to divide the ventricles into segments and predict each segment's probability to contain the activation wave source [28,37,66]. The latter aims at overcoming the problem of inter-patient variability as these segments can be defined on all ventricles.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Many studies have also successfully employed ML in arrhythmia risk stratification, including advanced ML-enabled image analysis (Feeny et al, 2020 ; Krittanawong et al, 2020 ; Trayanova, 2021 ). Recently, ML models have been combined with biophysical modeling to assess risk for dangerous arrhythmia as well as to uncover mechanisms of rhythm disturbances and to manage treatment for affected patients (Prakosa et al, 2013 ; Bernard et al, 2018 ; Lozoya et al, 2019 ; Shade et al, 2020 ; Banus et al, 2021 ; Monaci et al, 2021 ; Sermesant et al, 2021 ; Trayanova, 2021 ). Biophysical cardiac computational modeling and ML have also increasingly been combined to focus on drug-induced proarrhythmic risk assessment, as in e.g., Yang et al ( 2020 ) and Sahli-Costabal et al ( 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Many studies have also successfully employed ML in arrhythmia risk stratification, including advanced ML-enabled image analysis (Feeny et al, 2020;Krittanawong et al, 2020;Trayanova, 2021). Recently, ML models have been combined with biophysical modeling to assess risk for dangerous arrhythmia as well as to uncover mechanisms of rhythm disturbances and to manage treatment for affected patients (Prakosa et al, 2013;Bernard et al, 2018;Lozoya et al, 2019;Shade et al, 2020;Banus et al, 2021;Monaci et al, 2021;Trayanova, 2021). Biophysical cardiac computational modeling and ML have also increasingly been combined to focus on drug-induced proarrhythmic risk assessment, as in e.g., Yang et al (2020) and Sahli-Costabal et al (2020).…”
Section: Introductionmentioning
confidence: 99%